Jump to content
RemedySpot.com

trial recruiting: agent targets histone and non-histone deacetylation proteins

Rate this topic


Recommended Posts

Posted

From the sponsor:

" Arno is also developing AR-42 (formerly known as " HDAC-42 " ), an orally

available, broad spectrum inhibitor of both histone and non-histone

deacetylation proteins ( " pan-DAC " ), which may both be important in cancer

progression.

Histone deacetylase ( " HDAC " ) inhibitors are a growing class of compounds

that target histone deactylase, a molecule involved in determining which

genes are expressed in a particular cell.

This class has two approved agents, vorinostat ( " SAHA, " or ZolinzaR by

Merck) and romidepsin (IstodaxR, Celgene).

In preclinical studies, AR-42 has shown increased potency compared to SAHA,

activity against a broad spectrum of deacetylation targets, and unique

mechanisms for killing tumor-forming cancer stem cells (Hassane, et al).

Recently published preclinical research done in the lab of of Byrd, MD

at the Ohio State University demonstrated the in vitro and in vivo efficacy

of AR-42 against B-cell malignancites ? at tolerable doses, and these

results also suggested that AR-42 has greater efficacy in vitro as well as

in vivo compared to vorinostat (Lucas, et al).

[NOTE: I don't see how you can say " at tolerable doses " ahead of clinical

testing? - or that it will have greater efficacy - that is what you can find

out ONLY by clinical testing - in humans.]

This combination of activity and potency may provide for a toxicity and

efficacy profile that differentiates AR-42 from other HDAC inhibitors in

this emerging class of compounds.

Arno is currently enrolling an investigator-initiated Phase I/IIa study with

AR-42 in collaboration with The Ohio State University in adult patients with

relapsed or refractory multiple myeloma (MM), chronic lymphocytic leukemia

(CLL) or lymphoma

Study details: Safety/dose-finding trial: http://bit.ly/eG1aW5

All the best,

~ Karl

Patients Against Lymphoma

Patients Helping Patients

Non-profit | Independent | Evidence-based

www.lymphomation.org | Current News: http://bit.ly/f2A0T

How to Help: www.lymphomation.org/how-to-help.htm

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...